Primary Care Clinics in Muncie, IN Accepting Medicare
67 Primary Care Clinics found. Showing 61 - 67
 Quad/med, Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 2900 E Mcgalliard Rd, Muncie, IN 47303 Phone: 317-791-6691 Fax: 317-472-7498 |
Open Door Health Services, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 333 S Madison St, Muncie, IN 47305 Phone: 765-286-7000 Fax: 765-213-2769 |
Internal Medicine Plus, Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1816 W Royale Dr, Muncie, IN 47304 Phone: 765-282-9350 |
Open Door Health Services, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 1200 W Memorial Dr, Muncie, IN 47302 Phone: 765-286-7000 |
Jack Feliciano Md, Inc Internal Medicine Medicare: Medicare Enrolled Practice Location: 2401 W University Ave, Muncie, IN 47303 Phone: 765-751-5253 Fax: 765-282-8796 |
C & I Medical, Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1910 W Royale Dr, Muncie, IN 47304 Phone: 765-289-1011 Fax: 765-289-3024 |
Anodyne Of Muncie Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 3417 W Bethel Ave Ste A, Muncie, IN 47304 Phone: 765-281-8883 Fax: 765-281-8884 |
News Archive
Somaxon Pharmaceuticals, Procter & Gamble to co-promote Silenor
Somaxon Pharmaceuticals, Inc. today announced that Somaxon and Procter & Gamble have entered into a co-promotion agreement for Silenor (doxepin), a newly-approved treatment for insomnia characterized by difficulty with sleep maintenance.
Parkinson's-related mutations may also affect vision
The most common genetic cause of Parkinson's is not only responsible for the condition's distinctive movement problems but may also affect vision, according to new research by scientists at the University of York.
EpiCept's common stock included on a list of preliminary additions to Russell Microcap Index
EpiCept Corporation announced today that the Company's common stock has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Optogenetics: A promising technique for treatment of obsessive-compulsive disorders
By applying light stimulation to highly specific neurons in the brain, the researchers managed to re-establish normal behaviour in mice that had beforehand presented pathological repetitive behaviour similar to that observed in human patients suffering from obsessive-compulsive disorders.
› Verified 9 days ago